STAT — Reporting from the frontiers of health and medicine
- First Opinion The tyranny of the inbox: What it’s like to be a PCP with OCD
- Pharmalot STAT Plus: Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents
- Politics STAT Plus: Former Sen. Richard Burr to join health care practice at law and lobbying firm
- First Opinion 2022 was a breakthrough year for understanding rare diseases. 2023 needs to be better
- Health Care ‘They were his best shot. And they failed to help’: Why did EMS workers neglect Tyre Nichols?
- Living With After ‘losing my life’ caring for a sick partner, a professor examines the U.S. caregiver crisis
- First Opinion Covid convalescent plasma: the ‘little engine that could’
- First Opinion The tyranny of the inbox: What it’s like to be a PCP with OCD
- Pharmalot STAT Plus: Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents
- Politics STAT Plus: Former Sen. Richard Burr to join health care practice at law and lobbying firm
- First Opinion 2022 was a breakthrough year for understanding rare diseases. 2023 needs to be better
- Health Care ‘They were his best shot. And they failed to help’: Why did EMS workers neglect Tyre Nichols?
- Living With After ‘losing my life’ caring for a sick partner, a professor examines the U.S. caregiver crisis
- First Opinion Covid convalescent plasma: the ‘little engine that could’
Exclusive analysis of biotech, pharma, and the life sciences
- Exclusive Senators probe telehealth companies for tracking and monetizing sensitive health data
- First Opinion Mindstrong’s demise and the future of mental health care
- Health Care ‘They were his best shot. And they failed to help’: Why did EMS workers neglect Tyre Nichols?
-
- Living With After ‘losing my life’ caring for a sick partner, a professor examines the U.S. caregiver crisis
- Pharmalot STAT Plus: Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents
- Health Patient’s race and method of dialysis are linked to higher risk of blood infection
- First Opinion Unlocking the promise of learning from everyone with cancer
- First Opinion 2022 was a breakthrough year for understanding rare diseases. 2023 needs to be better
- Health Tech Mm-hm, uh-huh: AI-powered medical scribes still can’t understand our conversations
